[
  {
    "ts": null,
    "headline": "How Recent Developments Are Rewriting the Story for Medtronic Investors",
    "summary": "Medtronic’s stock narrative has recently shifted, as reflected in a modest rise in the consensus analyst price target from $99.90 to $101.13. This adjustment follows updated models from analysts who have responded to increasing investor optimism and anticipation surrounding key product launches. Stay tuned to discover how investors and observers can keep pace with these ongoing updates to Medtronic’s evolving outlook. What Wall Street Has Been Saying Analyst sentiment toward Medtronic has...",
    "url": "https://finnhub.io/api/news?id=35b8bc468b1a07ea69b4c0477748d2ac9ce0f88cbe5022f241633bbc3d8e07e5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761387042,
      "headline": "How Recent Developments Are Rewriting the Story for Medtronic Investors",
      "id": 137216606,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic’s stock narrative has recently shifted, as reflected in a modest rise in the consensus analyst price target from $99.90 to $101.13. This adjustment follows updated models from analysts who have responded to increasing investor optimism and anticipation surrounding key product launches. Stay tuned to discover how investors and observers can keep pace with these ongoing updates to Medtronic’s evolving outlook. What Wall Street Has Been Saying Analyst sentiment toward Medtronic has...",
      "url": "https://finnhub.io/api/news?id=35b8bc468b1a07ea69b4c0477748d2ac9ce0f88cbe5022f241633bbc3d8e07e5"
    }
  }
]